Biotech Values

[vinmantoo]

the spread between current price and buyout remains substantial for anyone looking to play this as an arbitrage opportunity. I would be tempted except for the risk to Adcetris from the front line PD-1 HL trial - that data came in better than I expected and I could see it pressuring Adcetris soon.

The spread is pretty large with the SGEN price today at $193 and the buyout at $229 so I understand the temptation. I am holding on and not selling shares until the price gets closer to the buyout price.

I do think the deal ultimately closes, and I really think we will know if it was a good deal for PFE once the lung cancer drug entering phase 3 (I forget the target) reads out.

PFE has a ton of cash so I don't care if the deal ends up good for them, meh for them or bad for them just as long as it is good for me! :)